Current methods for assessing differential rhythmicity in genomic data focus on hypothesis testing and model selection, often assuming sinusoidal rhythms. A more appropriate approach is to estimate differences in rhythmic properties between two or more conditions using effect sizes. To address this gap, we extend LimoRhyde2, a method for quantifying rhythm-related effect sizes and their uncertainty in genome-scale data, to enable differential rhythmicity analyses. Through extensive testing, we validate the method for differential rhythmicity analysis and showcase how it improves biological interpretation for circadian systems biology.
No takes yet. Share an insight, caveat, or question.
Obodo et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: